Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenylmercuric nitrate is an organomercury compound used primarily as an antimicrobial preservative in pharmaceutical formulations, especially ophthalmic (eye drop) preparations. It exhibits bactericidal activity against a broad spectrum of Gram-positive and Gram-negative bacteria. Historically, it has also been used as a germicide, fungicide, antiseptic, and spermicide (though its use in vaginal contraceptives is no longer recommended due to safety concerns). Its mechanism of action involves disruption of microbial cell membranes and enzyme systems through the interaction of mercury ions with thiol groups in proteins. Due to concerns about mercury toxicity—including ocular pigmentation changes after long-term use—its application has become limited[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenylmercuric nitrate.